Rome Resources Ltd. announce that it has fully exercised the second option under its option agreement with Andreas Friedrich Reitmeier and Medidoc-RD Congo SARLU dated the 15th day of August 2022, as amended the 6th day of June 2023 (MRDC Option Agreement). As a result, Rome has increased its earned undivided indirect interest in and to exploration permit PEPM 13274 from 21.75% to 51.475%. Pursuant to the MRDC Option Agreement, Rome initially acquired a 21.75% undivided interest in and to exploration permit PR 13274.

PR 13274 was subsequently converted to PEPM 13274. Rome has now acquired a further 29.725% indirect interest in PEPM 13274 (for a total indirect interest of 51.475%) by funding additional exploration expenditures totalling CAD 1,750,000 at exploration permit PEPM 13274 and by issuing a total of 30,000,000 RMR shares, of which 10,000,000 RMR shares were issued to Mark Gasson, the Company's president; 10,000,000 RMR shares were issued to Dr. Andreas Reitmeier and 10,000,000 RMR shares were issued to Klaus Eckhof. The 30,000,000 RMR shares are restricted from trading until April 20, 2024 and, in addition thereto, are subject to escrow provisions.

Rome now holds indirect interests of 51.475% in PEPM 13274 and 51% in PR 15130 and has an agreement in place to acquire an additional 15% interest in PR 15130.